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Abstract
The origin of hyperlactataemia during critical illness is complex but
its presence can provide an indicator of inadequate tissue oxygen
delivery. Cardiopulmonary bypass (CPB) represents a unique
situation where systemic oxygen delivery can be directly measured
and controlled. In the previous issue of Critical Care, Ranucci and
colleagues use this phenomenon to identify independent variables
associated with the development of hyperlactataemia during CPB.
In doing so they highlight the complexity of interpreting
hyperlactataemia during critical illness and provide further evidence
of its association with worse postoperative morbidity.
Introduction
The association of hyperlactataemia and acidosis with
worsened clinical outcome has been demonstrated in
numerous patient and disease states [1,2]. However, hyper-
lactataemia itself has complex origins and is variably associa-
ted with acidosis and with patient morbidity and mortality. The
latter depends greatly on the origin of lactate production.
‘Type A’ hyperlactataemia is associated with anaerobic
respiration, inadequate tissue oxygen delivery, acidosis, and
increased morbidity and mortality [3]. ‘Type B’ hyper-
lactataemia occurs in the presence of adequate oxygen
delivery with increased substrate utilisation. Differentiation
between these aetiologies is important because they
represent discrete metabolic processes with differing
therapies and prognoses. Hyperlactataemia developing during
cardiopulmonary bypass (CPB) is associated with worsened
postoperative outcome [4]; although ‘type A’ lactic acidosis is
the more commonly cited origin, this has been questioned [5].
Origin of hyperlactataemia during
cardiopulmonary bypass
In the previous issue of Critical Care, Ranucci and colleagues
report a prospective observational study undertaken to
identify the source of hyperlactatemia developing during CPB
and its association with outcome [1]. Data were analysed to
assess independent association between the tested variables
and the peak blood lactate concentration. They concluded
that hyperlactataemia was more likely during prolonged CPB
time, that it was independently associated with low oxygen
delivery, that it was almost invariably associated with hyper-
glycaemia, and that it was a predictor of worse postoperative
morbidity (although not mortality).
The association with low oxygen delivery is suggestive that
this underlies the mechanism for ‘type A’ hyperlactataemia,
but is not conclusive. Reduced oxygen delivery is compatible
with aerobic respiration if oxygen consumption is simul-
taneously decreased. Increased endogenous catecholamine
production during times of such ‘stress’ stimulates increased
blood glucose concentrations and glycolysis [6], with a
resultant increase in lactate production due to ‘flooding’ of
pyruvate dehydrogenase [7]. This is not an acidifying process
because it develops under aerobic conditions; it has been
termed ‘stress hyperlactataemia’ [8]. The presence or
absence of acidosis is therefore an important mechanism for
separating the aerobic and anaerobic aetiologies of
hyperlactataemia.
In Ranucci’s study [1], base excess was maintained within a
normal range during CPB by administrating bicarbonate
solution. No association can therefore be made between the
presence of hyperlactataemia and that of acidosis. This
information may be available in surrogate form as the dose of
bicarbonate required to maintain normal base excess levels in
patients with or without hyperlactataemia. If the dose
requirement for bicarbonate is significantly higher in the
hyperlactataemia group, then the presence of ‘type A’ lactic
acidosis can be inferred. However, if the bicarbonate
requirements are the same, it raises the possibility that this is
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stress-induced ‘type B’ hyperlactataemia. Another marker that
can separate the anaerobic and aerobic aetiologies of raised
lactate is the lactate:pyruvate ratio. Under aerobic conditions
with stimulated glycolysis, pyruvate synthesis increases in
proportion to lactate, giving a normal lactate:pyruvate ratio of
10:1. However, once anaerobic conditions develop, lactate
increases at a rate in excess of that for pyruvate, with a
resultant increase in their ratio [9]. The presence of an
increased lactate:pyruvate ratio in association with acidosis,
low oxygen delivery and hyperlactataemia during CPB would
be conclusive evidence that inadequate oxygen delivery and
anaerobic mechanisms are predominating.
Conclusion
The study by Ranucci and colleagues [1] highlights the
complexity involved in interpreting the significance of raised
serum lactate concentrations. It eloquently demonstrates the
association of reduced oxygen delivery in the development of
hyperlactataemia during CPB and illustrates the association
of the latter with greater morbidity during the postoperative
period. Further insight is gained into the significance of
monitoring serum lactate as a means of guiding oxygen
delivery during CPB. Future studies may definitively identify
‘type A’ lactic acidosis during critical illness by demonstrating
the concurrent association of hyperlactatemia, reduced tissue
oxygen delivery, increased lactate:pyruvate ratio and acidosis.
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